CAS 75949-61-0
:Pafenolol
Description:
Pafenolol is a chemical compound classified as a beta-adrenergic antagonist, commonly known as a beta-blocker. It is primarily used in the treatment of cardiovascular conditions, such as hypertension and certain types of arrhythmias. The compound works by blocking the action of catecholamines, such as adrenaline, on beta-adrenergic receptors, leading to a decrease in heart rate and blood pressure. Pafenolol exhibits lipophilic properties, which may influence its pharmacokinetics and distribution in the body. Additionally, it may have varying degrees of selectivity for beta-1 and beta-2 receptors, impacting its therapeutic profile and side effects. As with other beta-blockers, potential side effects can include fatigue, dizziness, and respiratory issues, particularly in patients with pre-existing conditions. The compound's safety and efficacy profile is typically evaluated through clinical studies, and it is essential for healthcare providers to consider individual patient factors when prescribing this medication. Overall, Pafenolol represents a significant option in the management of cardiovascular diseases.
Formula:C18H31N3O3
InChI:InChI=1S/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23)
InChI key:InChIKey=PKWZWSXSCKVUJB-UHFFFAOYSA-N
SMILES:O(CC(CNC(C)C)O)C1=CC=C(CCNC(NC(C)C)=O)C=C1
Synonyms:- N-[2-[4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethyl]-N′-(1-methylethyl)urea
- Pafenolol
- Urea, N-[2-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethyl]-N′-(1-methylethyl)-
- Urea, N-[2-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethyl]-N′-(1-methylethyl)-, (±)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Pafenolol
CAS:Pafenolol is a P-glycoprotein modulator with a Ki value of 5.5 µM. pafenolol is an orally available and selective beta-adrenergic receptor antagonist.Formula:C18H31N3O3Purity:98.33%Color and Shape:SolidMolecular weight:337.46
